Myeloma breakthrough: could some patients finally stop lifelong drugs?
NCT ID NCT04108624
First seen Mar 07, 2026 · Last updated May 16, 2026 · Updated 9 times
Summary
This study looks at whether multiple myeloma patients who have no signs of cancer after a stem cell transplant can safely stop their maintenance therapy. About 68 adults who have been on maintenance drugs for at least a year will be tested using advanced imaging and lab methods to see if the cancer is truly gone. If it is, they may stop treatment and be monitored to see if the cancer stays away.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.